Redicare Non-Aspirin, Acetaminophen 500mg
Brand Names: Redicare Non-Aspirin 500mg
Methodology & AI Transparency ⓘ
Redicare Non-Aspirin, Acetaminophen 500mg Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Uses: temporarily relieves minor aches and pains due to: ■ the common cold ■ headache ■ backache ■ minor pain of arthritis ■ toothache ■ muscular aches ■ premenstrual and menstrual cramps ■ temporarily reduces fever
- 2 Real-world patient consensus: Zero-PHI community consensus: 92% favorable across 11 logged regimens (Redicare Non-Aspirin 500mg).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $74.52 cash mean against $182.57 retail pharmacy pricing.
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Redicare Non-Aspirin, Acetaminophen 500mg): headache (8.5%), cutaneous rash (5.4%), nausea (7.9%).
Ask our AI Specialists anything about Redicare Non-Aspirin, Acetaminophen 500mg
Redicare Non-Aspirin, Acetaminophen 500mg Mechanism, CYP450 Pathways & DailyMed Monograph
Uses: temporarily relieves minor aches and pains due to: ■ the common cold ■ headache ■ backache ■ minor pain of arthritis ■ toothache ■ muscular aches ■ premenstrual and menstrual cramps ■ temporarily reduces fever
Biochemical activity of Redicare Non-Aspirin, Acetaminophen 500mg (NDC 71105-011) reflects over-the-counter clinical monograph receptor or enzymatic engagement paired with $1.6300/unit CMS NADAC reference benchmarks.
Following administration (500 mg/1 Tablet), Redicare Non-Aspirin, Acetaminophen 500mg achieves Approximately 70% to 82% enteral uptake across labeled Redicare Non-Aspirin, Acetaminophen 500mg strengths bioavailability and maximum serum exposure occurs 2–4 hours after redicare non-aspirin, acetaminophen 500mg dosing onset, governed by a Steady-state plasma equilibrium reached over 3–8 hour t½ intervals for Redicare Non-Aspirin, Acetaminophen 500mg terminal half-life through predominantly hepatic biotransformation with renal elimination of polar redicare non-aspirin, acetaminophen 500mg conjugates.
Before initiating Redicare Non-Aspirin, Acetaminophen 500mg at 500 mg/1 Tablet, clinical safety checklists rule out confirmed ige-mediated allergy or cutaneous reaction to redicare non-aspirin, acetaminophen 500mg (redicare non-aspirin, acetaminophen 500mg) components; uncompensated hepatic or renal insufficiency incompatible with redicare non-aspirin, acetaminophen 500mg (500 mg/1 tablet) clearance. Logged tolerability patterns center on headache (8.5% of reports), nausea (7.9% of reports), dizziness (5.5% of reports).
Reconcile eGFR-adjusted medications before escalating Redicare Non-Aspirin, Acetaminophen 500mg in polypharmacy regimens.
Unstandardized herbal extracts may interact pharmacodynamically with Redicare Non-Aspirin, Acetaminophen 500mg maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Redicare Non-Aspirin, Acetaminophen 500mg (Redicare Non-Aspirin, Acetaminophen 500mg) components
- Uncompensated hepatic or renal insufficiency incompatible with Redicare Non-Aspirin, Acetaminophen 500mg (500 mg/1 Tablet) clearance
Logged Side-Effect Incidence (11 Reports)
Redicare Non-Aspirin, Acetaminophen 500mg Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Redicare Non-Aspirin, Acetaminophen 500mg)
Human clinical trial evidence for Redicare Non-Aspirin, Acetaminophen 500mg is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Redicare Non-Aspirin, Acetaminophen 500mg Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.6300/unit (~$48.90/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $182.57 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 11 Anonymous DotMD Community Micro-Logs | $74.52 / mo | View logs ↓ |
Redicare Non-Aspirin, Acetaminophen 500mg Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Redicare Non-Aspirin, Acetaminophen 500mg RxNorm Concept ID | 198440 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.6300 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $182.57 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $74.52 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 92.00% Worth It (11 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Redicare Non-Aspirin, Acetaminophen 500mg Patient Community, Cohort Filters & Dosage Logs
Deterministic Redicare Non-Aspirin, Acetaminophen 500mg reference combining NIH RxNorm (198440), Medicaid NADAC ($1.6300/unit), and anonymous cohort outcomes (92% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Redicare Non-Aspirin, Acetaminophen 500mg community threads and patient logs by age, biological sex, dosage, and treatment duration.